ArticleJournal of family medicine and primary care2025
Prevalence and risk factors of diabetic nephropathy among type 2 diabetes patients in family medicine clinic AFHSR Khamis Mushait.
Article in Journal of family medicine and primary care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Association between serum lipid levels and the risk of diabetic nephropathy: a meta-analysis.Frontiers in endocrinology · 2026Pooled it
- Global, regional, and national burden of high body mass index-related type 2 diabetes from 1990 to 2021 and projections for 2040.Journal of family medicine and primary care · 2026Article
- Metformin Mitigates Diabetes-Driven Renal Senescence via Immunomodulation and the FABP4/FOXO1 Axis.Pharmaceuticals (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Diabetic nephropathy is a frequent complication of diabetes mellitus, affecting a considerable proportion of patients. Despite confirmed rising prevalence worldwide, little is known about its epidemiology in Saudi Arabia or its connection to glycemic or lipid parameters. Methods: This was a cross-sectional questionnaire-based observational study. We modeled the data using mixed effects logistic regression modeling. Results: Our sample was constituted of (n = 415) type 2 diabetes patients. The prevalence for diabetic nephropathy was [n = 17, 4.1% (95% confidence interval, CI: 3.7% to 4.4%)]. Unadjusted risk factors were older age profile, comorbid diabetic retinopathy, comorbid stroke, lower BMI, and injecting insulin. However, tobacco smoking, neuropathy, family history of diabetes, or renal disease did not bear any significant association with diabetes nephropathy among our participants. Risk factors related to glycemic and lipid profiles included initial FBG levels and HbA1c percentages and initial and later cholesterol and LDL levels. Initial and later HDL levels were protective from diabetic nephropathy. At the adjusted analysis, only the number of children (HR = 0.3151, Conclusion: Our estimate for diabetic nephropathy prevalence is exceedingly low compared to global figures. This may be related to impaired identification of diabetic nephropathy in Saudi Arabia. Our survey is the first in Saudi Arabia to confirm a link between reduced fertility and diabetic nephropathy. Our study, also, uniquely identifies a strong link between hypertriglyceridemia and diabetic nephropathy among Saudi patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.